Biomaterials are substances that treat, augment, or replace tissue, organs or body functions and are used regularly as components and elements in a wide variety of resorbable or permanent implants. Advances in materials technology and a better understanding of the biological processes involved in tissue formation and remodeling have led to the introduction of resorbable biomaterials-based products to address long-standing deficiencies of traditional products and therapies.

Kensey Nash Corporation (KNC) has vast experience with developing biomaterial implants for harnessing the body’s inherent ability to repair tissue damaged caused by disease, trauma or age. KNC is also developing a platform of biomaterials that are particularly useful for the controlled release of drugs and other biologically active agents.

Our current development programs encompass products for soft tissue repair, spine and trauma, orthobiologics and drug/device combinations. Several of our development programs address markets for which there are significant unmet clinical needs. These include cartilage regeneration, small diameter arterial substitution and controlled release drug delivery all of which more can be learned by visiting the links located on the left of this section.